Home -> Law Blog Directory -> Corporate Governance Blogs -> The Race to the Bottom
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Corporate Governance
: The Race to the BottomCEO Pay: Legislation Not a Solution
By Sandeep Gopalan
Last week's congressional hearings on CEO pay are just another manifestation of a deep schism in fundamental values over the acceptability of greed. The dispute is less about shareholder interests and much more about whether it is appropriate that some people make staggering amounts of money when their contributions are difficult to quantify. As Rep. Waxman noted in his opening statement "The CEOs of the 500 largest American companies received an average of $15 million each in 2006 - a 38% raise in just one year. In 1980, CEOs were paid 40 times the average worker. Today they are paid 600 times more. ... l0% of corporate profits are now flowing to the top executives."
Statistics like these are routinely trotted out by those in favour of regulatory solutions to protect shareholder interests. Yet, if it is shareholder interests that are truly at issue why is there so little scrutiny directed at the members of the board who approved compensation and severence packages? There is also inadequate attention devoted to the role of large shareholders who can use existing mechanisms to control egregious pay. There is evidence that the size of pay and severence packages can be kept in check if large institutional shareholders are engaged in corporate governance matters - like they are in the U.K.
In the first of three articles examining the various aspects of the excessive pay puzzle, I argue that social sanctions are preferable to any legal solutions. The paper can be downloadedhere.
Full post as published by The Race to the Bottom on March 13, 2008 (boomark / email).
Bausch Lomb Renu Moistureloc Linked to Eye Infection Fusarium Keratiti
Contact Lens Solution Product Recall
Bausch Lomb Renu Moistureloc Recall
Contact Lens Solution Product Recall
FFDA Issues Warning about Stolen Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution
Albuterol, Ipratropium FDA Warns Consumers not to Use
Personal Injury
Appeals Court Upholds Congressional Legislation

Podcast: The Wrong Solution for Reliable Energy
The result of knee-jerk legislation
Is videotaping interrogations a better solution
US Patent 7427328 - Nanowire solution deposition using electrostatic attraction







